<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910529-0040</DOCNO><DOCID>910529-0040.</DOCID><HL>   Business Brief -- Gelman Sciences Corp.:   `Modest' Operating Profit   Is Forecast for Fiscal 1991</HL><DATE>05/29/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   GSC</CO><MS>TECHNOLOGY (TEC)</MS><IN>DOW JONES INTERVIEW (CEO)MEDICAL AND BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)</IN><NS>EXCLUSIVE INTERVIEW WITH CHIEF EXECUTIVES (CEO)</NS><RE>MICHIGAN (MI)</RE><LP>   Gelman Sciences Corp., Ann Arbor, Mich., expects to post a&quot;modest profit&quot; on an operating basis for its fiscal yearending July 31, said Charles Gelman, chairman and chiefexecutive officer.   Gelman Science officials also said they expect profit to&quot;dramatically&quot; improve the next fiscal year, with salesgrowing by 10% to 15%.</LP><TEXT>   Company officials declined to comment on the outlook forfiscal third-quarter earnings, which they expect to announcein mid-June. Through the first half of the fiscal year, thecompany reported net of $360,000, or 15 cents a share. Thoseresults include a special one-time gain of $420,000, or 17cents a share, from selling assets.   In its 1990 fiscal year, Gelman had a net loss of $2million, or 84 cents a share.   The medical and industrial micro-filter maker hasn't paida dividend since going public in 1963 and doesn't anticipatepaying one in the next three years, Mr. Gelman said. Instead,the company this year will reduce long-term debt by $1million, and it plans to cut long-term debt by at least $2million in the coming fiscal year, he said in an interview.   The company's sales have grown slower than expected thisyear because of the general business slump and inventory cutsby distributors. In the first six months of this fiscal year,Gelman had net sales of $36.7 million, compared with $35.8million a year ago. The company reported sales of $73.3million in fiscal 1990.</TEXT></DOC>